Home > Drug Search >
  • company_query: Biowa
  •   > 
Drug Filter
Category:
chemistry (44) biology (7)
Status:
Approved (5) NDA Filing (1) Phase Ⅲ (3) Phase Ⅱ (26) Phase Ⅰ (16)
Clinical Stage:
Pending (3) Active (19) Discontinued (24)
Indication:
Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (1) Anxiety (4) Asthma (4) Atherosclerosis (1) Atrial fibrillation (1) Bladder cancer (1) BRAF mutant melanoma (1) Breast cancer (2) Cognitive disorders (1) Crohn's disease (1) Depression (2) Rheumatic disorders (1) Transplant rejection (1) Fibromyalgia (FM) (1) Fragile X syndrome (1) Huntington's disease (1) Hyperlipidemia (2) Insomnia (1) Major depressive disorder (MDD) (4) Melanoma (1) Migraine (1) Mood disorder (1) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (3) Ovarian cancer (2) Pancreatic cancer (1) Pleural mesothelioma (1) Postherpetic neuralgia (PHN) (1) Postoperative pain (1) Primary hypogonadism (1) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (1) Schizophrenia (4) Small cell lung cancer (SCLC) (1) Solid tumours (5) Colorectal cancer (4) Fallopian tube cancer (1) Advanced or metastatic transitional cell carcinoma (1) Stroke (1) Autistic disorder (1) Diabetes (1) Diagnostic agents (1) Post-traumatic stress disorder (1) Peritoneum cancer (1) Rett's syndrome (2) Brain injury (1) Thymic tumor (1) Thrombosis (1) Mesothelioma (1) Mild cognitive impairment(MCI) (1) Drug-induced dyskinesia (1) Coronary restenosis (1) Sciatica (1)
Country:
US (2) EU (1) FR (1)
Aprv. Year:
1996 (1) 2009 (1) 2013 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top